ADHD and Dyslexia
Conditions
Interventions
Co-morbid rTMS group:Repetitive transcranial magnetic stimulation
Co-morbid pseudo-rTMS group:Repetitive transcranial magnetic stimulation pseudotherapy
ADHD group:No clinical intervention
Sponsors
Yuyao Third People's Hospital
Eligibility
Sex/Gender
All
Age
9 Years to 12 Years
Inclusion criteria
Inclusion criteria: 1.ADHD group inclusion criteria. Inclusion criteria: (1).ADHD diagnosis according to ICD-11 criteria; (2).normal intelligence according to Wechsler Intelligence Scale for Children (WISC), age 9-12 years old; (3).native Chinese, right-handed; (4). total score >= 65 on the Children's Learning Disabilities Screening Scale (PRS) assessed by school teachers; (5). class rank in the average of the language scores and the elementary school Chinese character recognition is at the average; (6). the ability to (vi) Be able to cooperate in completing the examinations and treatments required for the trial. Translated with DeepL.com (free version); 2.Inclusion criteria for the co-morbid (ADHD co-morbid dyslexia) group: (1). ADHD and dyslexia diagnosis according to ICD-11 criteria; (2). Normal intelligence according to WISC scale, age 9-12 years old; (3). Native Chinese, right-handed; (4). Total score of PRS scale <65 points as measured by school teachers;(5). Class rank in the bottom 10% of language scores and lower-than-average recognition of Chinese characters in elementary school; (6). Able to cooperate with the completion of the examination and treatment. 1.5 standard deviations; (6). able to cooperate in completing the examinations and treatments required for the experiment.
Exclusion criteria
Exclusion criteria: 1.Exclusion criteria for the ADHD group: (1) history of severe organic brain diseases and mental disorders; (2) visual and hearing impairments; (3) previous treatment for ADHD; (4) no history of substance abuse, no other diseases that may affect the neural structure and function; and (5) other conditions that are not suitable for this study. 2.Exclusion criteria for the co-morbid (ADHD co-morbid dyslexia) group: (1) history of severe organic brain diseases and mental disorders; (2) visual and hearing impairments; (3) previous treatment for ADHD and reading problems; (4) no history of substance abuse or other diseases that may affect neurological structure and function; (5) patients with metallic implants (e.g., cardiac pacemaker, cochlear implants, etc.) or other contraindications to rTMS; (6) other conditions unsuitable for this study. Patients with metal implants (e.g., pacemakers, cochlear implants, etc.) or other contraindications to rTMS; and (6) other conditions that are not suitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scale assessment tools;Cognitive function assessment;Biological marker assessment; | — |
Countries
China
Contacts
Public ContactJia Wei
Yuyao Third People's Hospital
Outcome results
None listed